Search

Memorial Sloan Kettering has launched a collaborative translational research center that will unite researchers specializing in two rapidly growing fields: molecular imaging and nanotechnology.

… Friday, April 25, 2014 Memorial Sloan Kettering Cancer Center has launched a collaborative translational research center that will unite researchers specializing in two rapidly growing fields: molecular imaging and nanotechnology. The new Center for Molecular Imaging and Nanotechnology (CMINT) will speed

Learn what to do right after you've been diagnosed with colorectal cancer, from an MSK expert who specializes in treating this kind of cancer.

… Wednesday, February 25, 2026 They are four words that can make your world stop: “You have colorectal cancer.”  After the shock wears off, many people ask themselves, “What do I do now?”  They wonder: “Who should I trust with treatment? What options do I have for therapy? How will cancer affect my family

Cancer among younger Americans is on the rise, and much of it is linked to obesity. An MSK expert on diet and cancer explains what’s behind this disturbing new trend.

… Thursday, May 30, 2019 Summary Research has found that the incidence of several cancers is on the rise among younger adults in the United States. An MSK expert on diet and cancer explains how the obesity epidemic is to blame. There is a lot to celebrate in the battle against cancer. Research by the American

Memorial Sloan Kettering researchers have discovered a way that cancer cells may be able to exchange information by establishing long bridges between cells called tunneling nanotubes.

… Wednesday, September 19, 2012 Summary Memorial Sloan Kettering researchers have discovered a way that cancer cells may be able to exchange information by establishing long bridges between cells called tunneling nanotubes. Memorial Sloan Kettering researchers have discovered a way that cancer cells may

A phase 2 randomized clinical trial at MSK has found that acupuncture can improve cognitive abilities in breast cancer survivors experiencing "brain fog."

… Friday, December 12, 2025 Cancer-related cognitive impairment — often called “brain fog” or “chemo brain” — has been shown to affect about 40% of breast cancer survivors, making it difficult for them to focus, work, and perform daily tasks.  But acupuncture may help alleviate this brain fog, according

The July 22 MSK Science Spotlight features Luis Diaz, MD, Head of the Division of Solid Tumor Oncology and Grayer Family Chair, presenting his work on ”Immunotherapy of Mismatch Repair Deficient Tumors.”

… Wednesday, July 22, 2020 The July 22 MSK Science Spotlight features Luis Diaz, MD , Head of the Division of Solid Tumor Oncology and Grayer Family Chair, presenting his work on ”Immunotherapy of Mismatch Repair Deficient Tumors.” An accomplished physician, pioneering researcher, and leader in the field

You may have heard that the U.S. Food and Drug Administration (FDA) approved elacestrant for postmenopausal women or adult men with estrogen receptor (ER)-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer on January 27, 2023. In addition, the FDA also approved the Guardant360 CDx assay, a companion liquid biopsy diagnostic device for identifying patients for treatment.

… Wednesday, March 8, 2023 You may have heard that the U.S. Food and Drug Administration (FDA) approved elacestrant for postmenopausal women or adult men with estrogen receptor (ER)-positive, HER2-negative, ESR1 -mutated advanced or metastatic breast cancer on January 27, 2023. In addition, the FDA also

Researchers have produced a fully synthetic, functional version of erythropoietin, the hormone that controls production of red blood cells.

… Monday, October 8, 2012 Summary Researchers have produced a fully synthetic, functional version of erythropoietin, the hormone that controls production of red blood cells. For the first time, a team of Memorial Sloan Kettering investigators has synthesized erythropoietin (also known as EPO), the hormone

Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer discovery at the American Association for Cancer Research (AACR) Annual Meeting 2026, taking place April 17–22, in San Diego, California.

… Tuesday, April 14, 2026 Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer discovery at the American Association for Cancer Research (AACR) Annual Meeting 2026

Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the best cancer center in the Northeast, the number two cancer hospital in the nation, and the number one hospital for urology care by U.S. News & World Report in its annual Best Hospitals list. MSK has held its position as a top-two cancer hospital in the U.S. and the best cancer center in the Northeast since these rankings were established 35 years ago.

… Tuesday, July 16, 2024 Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the best cancer center in the Northeast, the number two cancer hospital in the nation, and the number one hospital for urology care by U.S. News & World Report in its annual Best Hospitals list. MSK has held its